Related Experiment Video
Updated: Jul 30, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
REALISIS: a medicinal chemistry-oriented reagent selection, library design, and profiling platform
Aziz Yasri1, Didier Berthelot, Harry Gijsen
1Johnson & Johnson Pharmaceutical Research and Development, a division of Janssen Pharmaceutica NV, Turnhoutseweg 30, B-23 40 Beerse, Belgium. yaziz_2000@yahoo.fr
REALISIS is a novel software system designed for efficient reagent selection and library design. This tool significantly reduces the time needed for creating chemical libraries, from days to mere hours.
Area of Science:
- Computational Chemistry
- Drug Discovery
- Cheminformatics
Background:
- Designing chemical libraries is a time-consuming process for medicinal chemists.
- Existing tools may not fully integrate the necessary functionalities for efficient library design.
Purpose of the Study:
- To introduce REALISIS, a software system for reagent selection, library design, and profiling.
- To streamline the workflow of bench and medicinal chemists.
- To reduce the time required for combinatorial and non-combinatorial library design.
Main Methods:
- REALISIS is a portable, component-based software system.
- It features a comprehensive graphical user interface.
- The system comprises four modules: reagent searching, reagent filtering, library enumeration, and library profiling.
Main Results:
- REALISIS provides rapid, integrated functionalities for reagent retrieval, filtering, product enumeration, and library profiling.
- Each module offers specific functionalities and diverse filtering/profiling mechanisms.
- The software integrates the entire process of reagent selection, library design, and profiling.
Conclusions:
- REALISIS significantly accelerates the design of chemical libraries.
- The software enhances the efficiency of medicinal and bench chemists.
- It offers a comprehensive solution for key aspects of library development.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
14:34A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...